OTC Markets OTCPK - Delayed Quote USD

Integral Diagnostics Limited (ITGDF)

Compare

2.1000

0.0000

(0.00%)

At close: November 15 at 3:00 PM EST

Currency in AUD All numbers in thousands

Download

Breakdown

TTM

6/30/2024

6/30/2023

6/30/2022

6/30/2021

Total Revenue

469,697.0000

440,099.0000

358,739.0000

348,808.0000

Cost of Revenue

22,920.0000

21,040.0000

19,221.0000

17,017.0000

Gross Profit

446,777.0000

419,059.0000

339,518.0000

331,791.0000

Operating Expense

404,609.0000

379,921.0000

303,086.0000

277,614.0000

Operating Income

42,168.0000

39,138.0000

36,432.0000

54,177.0000

Net Non Operating Interest Income Expense

-21,686.0000

-17,942.0000

-10,444.0000

-8,821.0000

Other Income Expense

-77,617.0000

9,437.0000

-3,427.0000

-134.0000

Pretax Income

-57,135.0000

30,633.0000

22,561.0000

45,222.0000

Tax Provision

3,564.0000

5,593.0000

7,958.0000

13,954.0000

Net Income Common Stockholders

-60,699.0000

25,040.0000

14,603.0000

31,268.0000

Basic EPS

-0.26

0.11

0.07

0.16

Diluted EPS

-0.26

0.11

0.07

0.15

Basic Average Shares

233,496.5340

232,718.7110

209,370.7310

200,675.8230

Diluted Average Shares

233,496.5340

236,226.4150

211,637.6810

203,227.7690

Net Income from Continuing & Discontinued Operation

-60,699.0000

25,040.0000

14,603.0000

31,268.0000

Normalized Income

9,312.3820

25,040.0000

14,603.0000

31,268.0000

Interest Income

861.0000

423.0000

39.0000

88.0000

Interest Expense

17,006.0000

18,365.0000

10,483.0000

8,909.0000

Net Interest Income

-21,686.0000

-17,942.0000

-10,444.0000

-8,821.0000

EBIT

-40,129.0000

48,998.0000

33,044.0000

54,131.0000

EBITDA

6,733.0000

92,484.0000

69,743.0000

89,044.0000

Reconciled Cost of Revenue

22,920.0000

21,040.0000

19,221.0000

17,017.0000

Reconciled Depreciation

46,862.0000

43,486.0000

36,699.0000

34,913.0000

Net Income from Continuing Operation Net Minority Interest

-60,699.0000

25,040.0000

14,603.0000

31,268.0000

Total Unusual Items Excluding Goodwill

-74,639.0000

Total Unusual Items

-74,639.0000

Normalized EBITDA

81,372.0000

92,484.0000

69,743.0000

89,044.0000

Tax Rate for Calcs

0.0001

0.0002

0.0004

0.0003

Tax Effect of Unusual Items

-4,627.6180

6/30/2021 - 2/2/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

FONR FONAR Corporation

15.03

-2.97%

MYGN Myriad Genetics, Inc.

15.25

-2.74%

CSTL Castle Biosciences, Inc.

28.10

-8.86%

CDNA CareDx, Inc

21.17

-1.76%

VCYT Veracyte, Inc.

35.94

-2.97%

NEO NeoGenomics, Inc.

15.04

-4.75%

DGX Quest Diagnostics Incorporated

160.44

+2.30%

FLGT Fulgent Genetics, Inc.

17.31

-2.70%

TWST Twist Bioscience Corporation

36.89

-5.31%

GH Guardant Health, Inc.

29.11

-3.64%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Integral Diagnostics Limited (ITGDF)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers